Hepatocyte Specific Expression of an Oncogenic Variant of Β-Catenin Results in Lethal Metabolic Dysfunction in Mice

Hepatocyte Specific Expression of an Oncogenic Variant of Β-Catenin Results in Lethal Metabolic Dysfunction in Mice

www.impactjournals.com/oncotarget/ Oncotarget, 2018, Vol. 9, (No. 13), pp: 11243-11257 Research Paper Hepatocyte specific expression of an oncogenic variant of β-catenin results in lethal metabolic dysfunction in mice Ursula J. Lemberger1,2, Claudia D. Fuchs2, Christian Schöfer3, Andrea Bileck4, Christopher Gerner4, Tatjana Stojakovic5, Makoto M. Taketo6, Michael Trauner2, Gerda Egger1,7 and Christoph H. Österreicher8 1Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria 2Hans Popper Laboratory for Molecular Hepatology, Department of Internal Medicine, Medical University of Vienna, Vienna, Austria 3Department of Cell and Developmental Biology, Medical University of Vienna, Vienna, Austria 4Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria 5Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria 6Division of Experimental Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan 7Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria 8Institute of Pharmacology, Medical University Vienna, Vienna, Austria Correspondence to: Ursula J. Lemberger, email: [email protected], [email protected] Keywords: Wnt signaling pathway; liver cancer; lipid metabolism; glucose metabolism; mitochondrial disorder Received: August 31, 2017 Accepted: January 25, 2018 Published: January 30, 2018 Copyright: Lemberger et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Background: Wnt/β-catenin signaling plays a crucial role in embryogenesis, tissue homeostasis, metabolism and malignant transformation of different organs including the liver. Continuous β-catenin signaling due to somatic mutations in exon 3 of the Ctnnb1 gene is associated with different liver diseases including cancer and cholestasis. Results: Expression of a degradation resistant form of β-catenin in hepatocytes resulted in 100% mortality within 31 days after birth. Ctnnb1CA hep mice were characterized by reduced body weight, significantly enlarged livers with hepatocellular fat accumulation around central veins and increased hepatic triglyceride content. Proteomics analysis using whole liver tissue revealed significant deregulation of proteins involved in fat, glucose and mitochondrial energy metabolism, which was also reflected in morphological anomalies of hepatocellular mitochondria. Key enzymes involved in transport and synthesis of fatty acids and cholesterol were significantly deregulated in livers of Ctnnb1CA hep mice. Furthermore, carbohydrate metabolism was substantially disturbed in mutant mice. Conclusion: Continuous β-catenin signaling in hepatocytes results in premature death due to severe disturbances of liver associated metabolic pathways and mitochondrial dysfunction. Methods: To investigate the influence of permanent β-catenin signaling on liver biology we analyzed mice with hepatocyte specific expression of a dominant stable form of β-catenin (Ctnnb1CA hep) and their WT littermates by serum biochemistry, histology, electron microscopy, mRNA profiling and proteomic analysis of the liver. www.impactjournals.com/oncotarget 11243 Oncotarget INTRODUCTION RESULTS The role of β-catenin has been extensively Continuous β-catenin signaling in hepatocytes investigated, highlighting its importance for organogenesis, leads to premature death in mice pattern formation, cell proliferation, tissue regeneration and apoptosis in different organs including the liver. Along In our previous work we showed that Ctnnb1CA hep these lines it has been shown that β-catenin is temporally mice, expressing a degradation resistant form of β-catenin, active during liver development and is essential for hepatic displayed severe deregulation of hepatic, renal and ileal morphogenesis and metabolic zonation [1, 2]. In adult transporters and disturbed liver architecture lacking lobule liver β-catenin is rather inactive but remains an important formation at weaning age [21]. To assess the long-term regulator of liver homeostasis [3]. consequences of β-catenin expression we performed Kaplan Hepatocyte specific deletion of β-catenin in mice Meier survival statistics (Figure 1A). All Ctnnb1CA hep mice (Ctnnb1Δhep) results in underdeveloped livers characterized died within 31 days after birth with a median survival time by immature hepatocytes, canalicular abnormalities, of 25 days. Ctnnb1CA hep mice were smaller and their body bile secretion defects and hence cholestasis and fibrosis weight was significantly reduced compared to their Cre- [4–6]. Moreover, Ctnnb1Δhep mice display impaired liver negative littermates (8.05 g vs. 9.22 g; Figure 1B). Livers regeneration after partial hepatectomy [7, 8]. Wnt/β- of Ctnnb1CA hep mice were significantly enlarged (0.92 g vs. catenin signaling is responsible for the heterogeneity 0.41 g; Figure 1C) resulting in an increased liver to body of hepatocytes, which results in a zonation with weight ratio (11.5% vs. 4.5%; Figure 1D). respect to metabolic processes. Periportal hepatocytes are predominantly involved in gluconeogenesis and Permanent active β-catenin leads to severe β-oxidation, while hepatocytes located around central deregulation of protein homeostasis in livers veins are responsible for glycolysis and lipogenesis. Close interaction between neighboring zones warrants quick and In order to study the lethal phenotype of constitutive flexible adaption in response to different demands and β-catenin signaling in hepatocytes in more detail, we ensures metabolic homeostasis [9, 10]. Disturbance of the performed whole liver proteomic analyses. Overall, 3853 Wnt signaling pathway affects the identity of hepatocytes individual proteins were identified by mass spectrometry resulting in perturbation of zonation and hence in analysis in livers of Ctnnb1CA hep and control mice, of metabolic liver disease [11–13]. which 3159 were unaltered and 694 proteins (21.9%) were Evidently, Ctnnb1Δhep mice are more susceptible to significantly deregulated in Ctnnb1CA hep mice compared develop steatohepatitis in response to metabolic stress to WT littermates, respectively (p-value < 0.05; 0.58 (MCD diet) and display aggravated steatohepatitis in log2 fold change in expression; Supplementary Table response to alcohol intake [14, 15]. Finally, β-catenin 1). From those, 343 proteins were up-regulated and 351 is one of the most frequently mutated genes involved in proteins were down-regulated in livers of Ctnnb1CA hep mice malignant transformation and plays also a pivotal role compared to WT littermates. (Figure 2A). in hepatic tumorigenesis [16]. Approximately 50% of In order to understand the biological relevance patients suffering from hepatocellular carcinoma (HCC), of the deregulated proteins we performed Ingenuity® up to 90% with hepatoblastoma (HB), and also patients Pathway Analysis (IPA), which revealed that up-regulated with benign hepatoadenoma (HA) display mutations in proteins were involved in canonical pathways including the Wnt/β-catenin pathway [17, 18]. The vast majority the superpathway of cholesterol biosynthesis, PXR/ of patients carry mutations located in exon 3 of the RXR function and estrogen biosynthesis (Figure 2B). CTNNB1 gene, resulting in a degradation resistant form Analyzing the significantly down-regulated proteins, of β-catenin [19]. These missense mutations in exon 3 the top deregulated canonical pathways identified were of CTNNB1 represent a subgroup of liver cancer with mitochondrial dysfunction, oxidative phosphorylation, distinctive clinical and pathological features [20]. We tryptophan degradation and the urea cycle (Figure 2C). recently presented a novel mouse model characterized by Moreover, up-regulated proteins were associated hepatocyte specific loss of exon 3 of Ctnnb1 (Ctnnb1CA with molecular functions related to different metabolic hep mice and Ctnnb1TCCA hep mice). The resulting truncated processes (lipids, nucleic acids, amino acids) and energy version of β-catenin is fully functional but resistant to production (Figure 2D). Analysis of down-regulated degradation. Using this model we demonstrated that proteins identified proteins involved in metabolic continuous expression of β-catenin in hepatocytes induces functions (lipids, vitamins and minerals, drugs), for energy cholestasis and a biliary type of fibrosis [21]. Following up production and carbohydrate metabolism (Figure 2D). on our previous study, here we analyzed the consequences When analyzed for liver toxicity we identified a strong of continuous β-catenin signaling on survival of Ctnnb1CA association of the deregulated proteins with liver steatosis, hep mice and observed major metabolic defects leading to liver cholestasis and hyperplasia/carcinoma for up- and premature death and mitochondrial dysfunction. down regulated proteins, respectively (Figure 2E). www.impactjournals.com/oncotarget 11244 Oncotarget Together, these data suggest that aberrant hepatic the liver. Interestingly, there was a decrease of non-HDL β-catenin signaling largely affects proteins involved in cholesterol levels in the serum of Ctnnb1CA hep mice (18.8 essential metabolic and energy production pathways in vs. 28.2 mg/dL; Figure 3G). No changes with regards to the liver. free fatty acid (FA) levels were observed (Supplementary

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    15 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us